Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Inflammatory Bowel Diseases
|
March 17, 2017
CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease
Aze Wilson, Rommel G Tirona, Richard B Kim
Inflammatory Bowel Diseases
|
May 18, 2021
IgA-Mediated Warm Autoimmune Hemolytic Anemia as an Extraintestinal Manifestation in a Patient With Crohn Disease on Vedolizumab
Matthew Cheah, Aze Wilson, Ziad Solh, et al.
Journal of the Canadian Association of Gastroenterology
|
December 5, 2022
Short-Term COVID-19 Pandemic-Related Endoscopy Delays Did Not Translate to Deleterious Outcomes for Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study
Jason Chambers, Gurpreet Malhi, Maria Mikail, et al.
Scientific Reports
|
February 7, 2020
Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's disease
Aze Wilson, Ahmed Almousa, Wendy A Teft, et al.
Journal of Periodontology
|
July 5, 2007
Juvenile spongiotic gingivitis
Mark R Darling, Tom D Daley, Aze Wilson, et al.
Journal of the Canadian Association of Gastroenterology
|
December 5, 2022
Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic
Gurpreet Malhi, Gurjot Minhas, Jason Chambers, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 2020
Letter: immunogenicity of infliximab-ready for routine prediction? Authors' reply
Aze Wilson, Celeste Peel, Qian Wang, et al.
Pharmacogenetics and Genomics
|
November 9, 2021
A novel NUDT15 variant identified in Caucasian TPMT wild type patients with inflammatory bowel disease and azathioprine-related myelotoxicity
Qian Wang, Jaymie Mailloux, Ute I Schwarz, et al.
Alimentary Pharmacology & Therapeutics
|
October 26, 2019
HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease
Aze Wilson, Celeste Peel, Qian Wang, et al.
Inflammatory Bowel Diseases
|
September 16, 2022
Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A Genotype
Bethany Choi, Michael Sey, Terry Ponich, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Inflammatory Bowel Diseases
|
March 17, 2017
CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease
Aze Wilson, Rommel G Tirona, Richard B Kim
Inflammatory Bowel Diseases
|
May 18, 2021
IgA-Mediated Warm Autoimmune Hemolytic Anemia as an Extraintestinal Manifestation in a Patient With Crohn Disease on Vedolizumab
Matthew Cheah, Aze Wilson, Ziad Solh, et al.
Journal of the Canadian Association of Gastroenterology
|
December 5, 2022
Short-Term COVID-19 Pandemic-Related Endoscopy Delays Did Not Translate to Deleterious Outcomes for Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study
Jason Chambers, Gurpreet Malhi, Maria Mikail, et al.
Scientific Reports
|
February 7, 2020
Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's disease
Aze Wilson, Ahmed Almousa, Wendy A Teft, et al.
Journal of Periodontology
|
July 5, 2007
Juvenile spongiotic gingivitis
Mark R Darling, Tom D Daley, Aze Wilson, et al.
Journal of the Canadian Association of Gastroenterology
|
December 5, 2022
Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic
Gurpreet Malhi, Gurjot Minhas, Jason Chambers, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 2020
Letter: immunogenicity of infliximab-ready for routine prediction? Authors' reply
Aze Wilson, Celeste Peel, Qian Wang, et al.
Pharmacogenetics and Genomics
|
November 9, 2021
A novel NUDT15 variant identified in Caucasian TPMT wild type patients with inflammatory bowel disease and azathioprine-related myelotoxicity
Qian Wang, Jaymie Mailloux, Ute I Schwarz, et al.
Alimentary Pharmacology & Therapeutics
|
October 26, 2019
HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease
Aze Wilson, Celeste Peel, Qian Wang, et al.
Inflammatory Bowel Diseases
|
September 16, 2022
Decreased Infliximab Concentrations in Patients With Inflammatory Bowel Disease Who Carry a Variable Number Tandem Repeat Polymorphism in the Neonatal Fc Receptor or Variant HLADQA1*05G>A Genotype
Bethany Choi, Michael Sey, Terry Ponich, et al.
Page
of 5